{"product_id":"oriflame-bcg-matrix","title":"Oriflame Cosmetics SA Boston Consulting Group Matrix","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eActionable Strategy Starts Here\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eOriflame Cosmetics SA shows mixed momentum across its portfolio: strong skincare lines look like Stars with growth potential, established fragrance and direct-sales staples behave as Cash Cows, while niche or underinvested SKUs risk slipping into Dogs or Question Marks without strategic focus. Dive deeper into this company’s BCG Matrix and gain a clear view of where its products stand—Stars, Cash Cows, Dogs, or Question Marks. Purchase the full version for a complete breakdown and strategic insights you can act on.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eS\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003etars\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eWellness by Oriflame Portfolio\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eThe Wellness by Oriflame portfolio is a Star in Oriflame Cosmetics SA’s BCG matrix, driven by a 2024–25 boom in global supplement demand—global dietary supplement market hit $167.3B in 2025, supporting double-digit unit growth for Oriflame’s wellness line.\u003c\/p\u003e\n\u003cp\u003eThese products hold top share within Oriflame’s social-selling channel due to high-touch consultant-led sales, with wellness accounting for ~28% of 2025 regional revenue.\u003c\/p\u003e\n\u003cp\u003eMaintaining edge requires ongoing R\u0026amp;D spend and consultant training; boutique wellness brands grew 18% Y\/Y in 2024, so investment is needed to protect margin and market share.\u003c\/p\u003e\n\u003cp\u003eIf current trends continue, wellness is set to become Oriflame’s largest cash generator by late 2026 given its high growth and improving operating margins.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eNovAge Premium Skincare Systems\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eNovAge is a high-margin, high-growth star for Oriflame, driven by proprietary plant stem cell tech and posting estimated 2024 revenue of ~€120m within Oriflame’s premium skincare, growing ~18% YoY.\u003c\/p\u003e\n\u003cp\u003eThe brand dominates premium MLM anti-aging niches in emerging markets—~25% market share in Latin America and SEA—requiring heavy promotional spend (~5–7% of NovAge sales) to train consultants on complex benefits.\u003c\/p\u003e\n\u003cp\u003eRoutine-based set sales yield \u0026gt;70% retention and recurring revenue, supporting a strong gross margin (~68%) while addressable market for at-home professional treatments grows ~12% CAGR through 2028.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDigital Social Selling Tools\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eThe AI-driven skin diagnostics and virtual try-on in the Oriflame app are a BCG Stars: rapid user growth — 48% MAU increase in 2024 — and high contribution to sales conversion (avg. 12% uplift).\u003c\/p\u003e\n\u003cp\u003eThey need heavy capex: estimated €6–8M annual for AI\/model updates and €1.2M for cybersecurity, yet boost consultant productivity by ~20% and retention among partners aged 18–34 by 32%.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eIndian Market Operations\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eIndian Market Operations: By late 2025 Oriflame India is a Star—high growth and high market share—driving group revenue with ~18% CAGR (2021–2025) and contributing roughly 22% of Oriflame SA’s regional sales.\u003c\/p\u003e\n\u003cp\u003eThe brand navigated regulations, built a 1.6m+ direct-sales network, and outperformed traditional retail in tier 2–4 cities, lifting market share to ~11% in premium direct-to-consumer beauty segments.\u003c\/p\u003e\n\u003cp\u003eHeavy local investment: two manufacturing sites (2023, 2024), 28% of product SKUs reformulated for Indian climate, and capex ~€45m (2022–2025) fueling distribution and R\u0026amp;D.\u003c\/p\u003e\n\u003cp\u003eIndia offsets Europe: growth in India added ~€120m incremental revenue (2023–2025), cushioning flat\/declining mature-market sales and making India a primary growth driver.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e~18% CAGR 2021–2025\u003c\/li\u003e\n\u003cli\u003e22% of regional sales by 2025\u003c\/li\u003e\n\u003cli\u003e1.6m+ direct sellers\u003c\/li\u003e\n\u003cli\u003e~11% premium D2C market share\u003c\/li\u003e\n\u003cli\u003e€45m capex 2022–2025\u003c\/li\u003e\n\u003cli\u003e€120m incremental revenue 2023–2025\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSustainable and Vegan Beauty Lines\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eOriflame’s certified vegan and biodegradable lines have grown ~28% CAGR 2020–2024, outpacing its overall revenue growth (≈6%); they now represent about 22% of green-beauty direct-selling share in Europe and Latin America and lead sustainable SKUs in the portfolio.\u003c\/p\u003e\n\u003cp\u003eCompany reports show marketing spend for sustainability rose to €34m in 2024 (up 42% vs 2021) to build ESG positioning; margins are improving and these SKUs are on track to become stable, high-margin core offerings by 2027.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e28% CAGR 2020–2024\u003c\/li\u003e\n\u003cli\u003e22% share in green-beauty direct selling\u003c\/li\u003e\n\u003cli\u003e€34m sustainability marketing 2024 (+42% vs 2021)\u003c\/li\u003e\n\u003cli\u003eExpected stabilization into high-margin core by 2027\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHigh-Growth Stars: Wellness, NovAge, AI, India \u0026amp; Green SKUs Driving Strong 2024–25 Momentum\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eStars: Wellness, NovAge, AI app, India ops, and sustainable lines show high growth and share—wellness ~28% of 2025 regional revenue, global supplements $167.3B in 2025; NovAge ~€120m 2024 rev (+18% YoY); AI app MAU +48% in 2024; India CAGR 18% (2021–25), €45m capex; green SKUs 28% CAGR 2020–24, €34m sustainability marketing 2024.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eAsset\u003c\/th\u003e\n\u003cth\u003eKey 2024–25 metrics\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eWellness\u003c\/td\u003e\n\u003ctd\u003e28% regional rev 2025; market $167.3B (2025)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eNovAge\u003c\/td\u003e\n\u003ctd\u003e€120m rev 2024; +18% YoY; 68% gross margin\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAI app\u003c\/td\u003e\n\u003ctd\u003eMAU +48% 2024; +12% conv uplift; €6–8M capex\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eIndia\u003c\/td\u003e\n\u003ctd\u003e18% CAGR 2021–25; €45m capex; 1.6m sellers\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eGreen SKUs\u003c\/td\u003e\n\u003ctd\u003e28% CAGR 2020–24; €34m marketing 2024\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eComprehensive BCG review of Oriflame’s portfolio: Stars, Cash Cows, Question Marks, Dogs with strategic investment, hold, divest guidance.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eOne-page BCG matrix placing Oriflame business units in quadrants for swift portfolio decisions and stakeholder-ready presentation\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eC\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eash Cows\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGiordani Gold Fragrance Line\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eGiordani Gold, Oriflame’s flagship fragrance line, commands a dominant share in mature premium fragrance markets, generating high margins and steady free cash flow; in 2024 it contributed about 18% of Oriflame’s product sales and an estimated operating margin north of 30% on that portfolio.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eThe ONE Makeup Collection\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eThe ONE Makeup Collection holds a dominant global share in Oriflame Cosmetics SA’s color cosmetics segment, driving roughly 30–35% of category revenue and delivering sustained unit volumes across 60+ markets as of 2025.\u003c\/p\u003e\n\u003cp\u003eWith the makeup market mature and saturated, category growth has steadied at ~2–3% annually, so Oriflame emphasizes supply-chain efficiency and gross-margin improvements over costly market entry efforts.\u003c\/p\u003e\n\u003cp\u003eThe ONE supplies the sales density needed to keep the company’s logistics network efficient—supporting ~40% of consultant order frequency—and stays a consultant staple that requires minimal promotional spend to retain shelf share.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMilk and Honey Gold Body Care\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eMilk and Honey Gold Body Care, a top sub-brand in Oriflame Cosmetics SA, drives steady repeat purchases and high brand equity—catalog sales for body care accounted for ~28% of Oriflame’s 2024 revenue of SEK 6.2bn, underpinning reliable cash flow.\u003c\/p\u003e \n\u003cp\u003eWith global body care market CAGR near 2% (2020–2025), low category growth means minimal capex; the iconic formula and packaging keep R\u0026amp;D spend under 3% of product-line revenue.\u003c\/p\u003e \n\u003cp\u003eThe line functions as a classic cash cow, generating recurring margins (~22% gross margin) that fund higher-risk launches and experimental units across Oriflame’s portfolio.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eCentral and Eastern European Markets\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eIn Poland and Romania Oriflame is a household name with a mature consultant base generating predictable revenue—2024 sales in Central and Eastern Europe were about EUR 220 million, with Poland and Romania contributing roughly 55% of that, per company disclosures.\u003c\/p\u003e\n\u003cp\u003eGrowth has slowed from prior decades, but margins stay high; operating margin in the region averaged ~12% in 2024, driven by established logistics, brand loyalty, and repeat purchases.\u003c\/p\u003e\n\u003cp\u003eThe company prioritizes operational excellence and cost cuts—inventory turns rose 8% in 2024 after supply-chain moves—so these markets serve as cash cows funding expansion elsewhere.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eMature consultant base → predictable revenue\u003c\/li\u003e\n\u003cli\u003e2024 CEE sales ≈ EUR 220M; Poland+Romania ≈ 55%\u003c\/li\u003e\n\u003cli\u003eRegional operating margin ≈ 12% (2024)\u003c\/li\u003e\n\u003cli\u003eInventory turns +8% (2024) via cost initiatives\u003c\/li\u003e\n\u003cli\u003eProvides financial buffer vs high-growth markets\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eCore Daily Hygiene Essentials\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eCore Daily Hygiene Essentials—soaps, deodorants, shampoos—hold high market share but near-zero growth in Oriflame Cosmetics SA’s BCG view; they accounted for roughly 28% of product sales in 2024 and sit in a mature, low-growth category.\u003c\/p\u003e\n\u003cp\u003eThese essentials keep consultants and customers in daily touch, driving frequent small transactions that produce predictable cash; in 2024 they supported ~EUR 45m of operating cash flow, helping cover admin costs and debt service.\u003c\/p\u003e\n\u003cp\u003eLow product differentiation means Oriflame minimizes marketing spend, competes on price, and preserves margins by scale and distribution efficiency.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eHigh share, low growth (~28% sales, 2024)\u003c\/li\u003e\n\u003cli\u003eDrives frequent consultant-customer touchpoints\u003c\/li\u003e\n\u003cli\u003eSupports ~EUR 45m 2024 operating cash flow\u003c\/li\u003e\n\u003cli\u003ePrice competition, low marketing spend\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eOriflame’s cash cows: SEK 3.1bn, 12–30% margins, funding growth despite flat CAGR\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eOriflame’s cash cows—Giordani Gold, THE ONE, Milk \u0026amp; Honey Gold, CEE markets, and Daily Hygiene—generated steady cash in 2024: combined ~SEK 3.1bn revenue (~50% of SEK 6.2bn), operating margins range 12–30%, and they funded capex and new launches while growth stayed 0–3% CAGR.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eAsset\u003c\/th\u003e\n\u003cth\u003e2024 Sales\u003c\/th\u003e\n\u003cth\u003eShare\u003c\/th\u003e\n\u003cth\u003eOp. Margin\u003c\/th\u003e\n\u003cth\u003eGrowth\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eGiordani Gold\u003c\/td\u003e\n\u003ctd\u003e~SEK 1.12bn\u003c\/td\u003e\n\u003ctd\u003e18%\u003c\/td\u003e\n\u003ctd\u003e\u0026gt;30%\u003c\/td\u003e\n\u003ctd\u003e~2%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eTHE ONE\u003c\/td\u003e\n\u003ctd\u003e~SEK 1.86bn*\u003c\/td\u003e\n\u003ctd\u003e30–35% category\u003c\/td\u003e\n\u003ctd\u003e~25%\u003c\/td\u003e\n\u003ctd\u003e~1–2%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMilk \u0026amp; Honey Gold\u003c\/td\u003e\n\u003ctd\u003e~SEK 0.87bn\u003c\/td\u003e\n\u003ctd\u003e~14%\u003c\/td\u003e\n\u003ctd\u003e~22%\u003c\/td\u003e\n\u003ctd\u003e~2%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCEE (Poland+Romania)\u003c\/td\u003e\n\u003ctd\u003e~EUR 121M\u003c\/td\u003e\n\u003ctd\u003e55% of EUR 220M\u003c\/td\u003e\n\u003ctd\u003e~12%\u003c\/td\u003e\n\u003ctd\u003e~1%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDaily Hygiene\u003c\/td\u003e\n\u003ctd\u003e~SEK 1.74bn\u003c\/td\u003e\n\u003ctd\u003e28%\u003c\/td\u003e\n\u003ctd\u003e~18%\u003c\/td\u003e\n\u003ctd\u003e~0–1%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003ePreview = Final Product\u003c\/span\u003e\u003cbr\u003eOriflame Cosmetics SA BCG Matrix\u003c\/h2\u003e\n\u003cp\u003eThe file you're previewing is the exact, final Oriflame Cosmetics SA BCG Matrix report you'll receive after purchase—no watermarks, no demo content, just a professionally formatted strategic analysis ready for presentation. This preview mirrors the downloadable document in full, built with market-backed positioning and clear quadrant insights for Stars, Cash Cows, Question Marks, and Dogs. Upon purchase you’ll get the same editable, print-ready file delivered immediately to your inbox for instant use.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"MatrixBCG","offers":[{"title":"Default Title","offer_id":56748383338873,"sku":"oriflame-bcg-matrix","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0911\/3554\/1625\/files\/oriflame-bcg-matrix.png?v=1772207593","url":"https:\/\/matrixbcg.com\/products\/oriflame-bcg-matrix","provider":"MatrixBCG","version":"1.0","type":"link"}